HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Franz, K. H. Articles by Pohlman, M. H. Search for Related Content PubMed PubMed Citation Articles by Franz, K. H. Articles by Pohlman, M. H.

Clinical Trials with Thiabendazole against Intestinal Nematodes Infecting Humans^*

K. H. Franz, W. J. Schneider AND M. H. Pohlman

Thiabendazole was administered orally in a suspension to 163 adults and children and found to be very effective against Ancylostoma duodenale, Ascaris lumbricoides, Necator americanus and Strongyloides stercoralis and slightly effective against Trichuris trichiura. Five treatment regimens were used and evaluated. A dosage of 25 to about 30 mg of thiabendazole per kg of body weight twice daily for 3 days was very effective and well tolerated. This was substantiated by the results obtained in a double-blind placebocontrolled study. Side effects were few with this regimen. With all treatment regimens side effects were transitory and not severe.

^* Presented in part at the First International Congress of Parasitology in Rome, Italy, September 21–26, 1964.

Medical Director, Firestone Plantations Company, Harbel, Liberia.

Present address: The New York Hospital, New York, New York 10021.

Present address: The Mary Imogene Bassett Hospital, Cooperstown, New York.

This article has been cited by other articles:

				H. M. Robinson Jr and C. S. Samorodin Thiabendazole-Induced Toxic Epidermal Necrolysis Arch Dermatol, December 1, 1976; 112(12): 1757 - 1760. [Abstract] [PDF]